Brain Mechanism and Outcome of Surgical Intervention of Conductive Hearing Loss.

The Brain Network Mechanism and Outcome After Surgical Intervention of Conductive Hearing Loss Accompanied by Tinnitus.

This study explores the brain region activation and remodeling of poor connections of brain regions in the postoperative outcomes of conductive hearing loss patients with tinnitus by comparing pre - and post-operative audiological assessment, tinnitus assessment and EEG data.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study explores the brain region activation and remodeling of poor connections of brain regions in the postoperative outcomes of conductive hearing loss patients with tinnitus by comparing pre - and post-operative audiological assessment, tinnitus assessment and EEG data. Including audiological assessment (pure tone audiometry, speech test), tinnitus assessment (tinnitus matching, tinnitus handicap inventory, tinnitus function index, visual analogue scale)and non-invasive brain imaging assessment (EEG, fNIRS).

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged between 18 and 60 years;
  • diagnosed with conductive hearing loss with tinnitus;
  • treated with surgery;
  • able to cooperate with all Chinese version evaluation;
  • right-handed.

Exclusion Criteria:

  • Pure tone audiometry indicates that the average pure tone hearing threshold (500Hz, 1kHz, 2kHz, 4kHz) is > 91dB HL;
  • acoustic neuroma, nasopharyngeal carcinoma;
  • hearing loss caused by noise or drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: baseline
pre-operative period test results
Other: follow-up
post-operative period test results
Surgical treatment of conductive hearing loss with tinnitus

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pure tone audiometry
Time Frame: 3-7 days before surgery, 1-12 months after surgery
The air- conducted threshold, bone-conducted threshold and air- bone gap of each frequency of pure tone audiometry were used to compare pre - and post-operative hearing level.
3-7 days before surgery, 1-12 months after surgery
speech test
Time Frame: 3-7 days before surgery, 1-12 months after surgery
Speech audiometry was mainly used to analyze the speech recognition rate of patients before and after surgery
3-7 days before surgery, 1-12 months after surgery
EEG activation
Time Frame: 3-7 days before surgery, 1-12 months after surgery
EEG signals were used to explore the activation of brain regions and remodeling of poor connections in the postoperative outcomes of conductive hearing loss patients accompanied by with tinnitus. Power spectral density calculation, traceability analysis, functional connection, microstate, clustering coefficient, feature path length, feature path intermediation, and isocompatibility coefficient were collected and then analyzed.
3-7 days before surgery, 1-12 months after surgery
tinnitus handicap inventory scores
Time Frame: 3-7 days before surgery, 1-12 months after surgery
The total score of the THI scale and the scores of the three subscales(functional, emotional, and catastrophic) were collected before and after surgery for data analysis.
3-7 days before surgery, 1-12 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tinnitus function index scores
Time Frame: 3-7 days before surgery, 1-12 months after surgery
The total score of the TFI scale were collected before and after surgery for data analysis.
3-7 days before surgery, 1-12 months after surgery
visual analogue scale
Time Frame: 3-7 days before surgery, 1-12 months after surgery
The total score of the VAS were collected before and after surgery for data analysis. VAS scale 0-10. A score of 0 means that tinnitus has no impact on daily life, and a score of 10 means that tinnitus has an intolerable, fatal level of impact on daily life.
3-7 days before surgery, 1-12 months after surgery
fNIRS activation
Time Frame: 3-7 days before surgery, 1-12 months after surgery
fNIRS signals were used to explore the activation of brain regions and remodeling of poor connections in the postoperative outcomes of conductive hearing loss patients accompanied by with tinnitus. Power spectral density calculation, traceability analysis, functional connection, microstate, clustering coefficient, feature path length, feature path intermediation, and isocompatibility coefficient were collected and then analyzed.
3-7 days before surgery, 1-12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

May 22, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

July 30, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on surgery

Subscribe